Suchergebnisse - "Taieb, Julien"

PubPharm (479)

1

Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60) : a randomised, non-comparative, phase 2 study

enthalten in: The Lancet. Oncology | 2024

von Kim, S. | Ghiringhelli, F. | de la Fouchardière, C. | +25

2

A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Moreau, M. | Alouani, E. | Flecchia, C. | +24

3

Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer

enthalten in: Journal of translational medicine | 2024

von Mouillet-Richard, S. | Gougelet, A. | Passet, B. | +19

4

Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer

enthalten in: Journal of translational medicine | 2024

von Mouillet-Richard, S. | Gougelet, A. | Passet, B. | +19

5

Clinical challenges of consensus molecular subtype CMS4 colon cancer in the era of precision medicine

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Mouillet-Richard, S. | Cazelles, A. | Sroussi, M. | +3

6

Progression-Free Survival Analysis With a Graphical Estimand Approach in the Phase 2 SAMCO-PRODIGE 54 Trial-Reply

enthalten in: JAMA oncology | 2024

von Boussari, O. | Taïeb, J.

7

Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer : An ACCENT/IDEA Pooled Analysis of 12 Trials

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Gallois, C. | Shi, Q. | Pederson, L. | +22

8

Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity : FUSAFE individual patient data meta-analysis

enthalten in: British journal of cancer | 2024

von Le Teuff, G. | Cozic, N. | Boyer, J. | +27

9

SEAMARK : phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR BRAFV600E-mutant mCRC

enthalten in: Future oncology (London, England) | 2024

von Elez, E. | Kopetz, S. | Tabernero, J. | +8

10

Non-metastatic colon cancer : French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR)

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2024

von Lecomte, T. | Tougeron, D. | Chautard, R. | +27

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[48]